|
Real-time Estimate
Cboe Europe
13:01:06 02/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 1,869.25 GBX | -0.12% |
|
-1.76% | +2.27% |
| 09-01 | Gsk Advances Mrna Flu Vaccine Candidate to Phase Iii Following Positive Phase Ii Data | CI |
| 09-01 | European Stocks Close Mostly Lower in Tuesday Trading; Euro Area Inflation Surges in August | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK PLC | Other Pharmaceuticals | -0.24% | -1.76% | +2.27% | +29.36% | +1.12% | 101B |  |  |  |
- Stock Market
- Stocks
- GSK Stock
- Charts GSK plc
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
